Howard Birndorf
Director/Board Member chez DMK PHARMACEUTICALS CORPORATION
Fortune : - $ au 31/03/2024
Profil
Howard C.
Birndorf is the founder of Hybritech, Inc. (founded in 1978), Ngen, Inc. (founded in 1991), and BCM Benefits LLC (founded in 1998).
He is also the founder of 21st Century Media, Ligand Pharmaceuticals, Inc., Gen-Probe, Inc., IDEC Pharmaceuticals Corp., and The Coalition for 21st Century Medicine.
Dr. Birndorf's current job(s) include Chairman at FasTraq, Inc., Chairman at Ha Cell Technology, Inc., and Independent Director at DMK Pharmaceuticals Corp.
(since 2019).
His former job(s) include Director at Neurocrine Biosciences, Inc. (1992-1997), Director at Gensia Pharmaceuticals, Inc., Director at Jurilab Oy, and President at Birndorf Technology Development (1991-1993).
Dr. Birndorf's education history includes a graduate degree from Wayne State University (Michigan) and an undergraduate degree from Oakland University (Michigan).
Dr. Birndorf is also the founder of 21st Century Media, Ligand Pharmaceuticals, Inc., Gen-Probe, Inc., IDEC Pharmaceuticals Corp., and The Coalition for 21st Century Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/10/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Howard Birndorf
| Sociétés | Poste | Début |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | Director/Board Member | 26/08/2019 |
BCM Benefits LLC
 BCM Benefits LLC Investment ManagersFinance BCM Benefits LLC provides investment advice. The private company is based in Syracuse, NY. The company was founded by Howard C. Birndorf, Stanley J. Bradshaw. | Founder | 06/01/2010 |
| Ha Cell Technology, Inc. | Chairman | - |
FasTraq, Inc.
 FasTraq, Inc. Medical SpecialtiesHealth Technology FasTraq, Inc. provides blood diagnosis solutions. The company's product includes FasTraQ ER-CPC workstation. It was founded in 2002 and is headquartered in Henderson, NV. | Chairman | - |
Anciens postes connus de Howard Birndorf
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Director/Board Member | 01/01/1997 |
| Birndorf Technology Development | President | 01/01/1993 |
| The Coalition for 21st Century Medicine | Founder | - |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Founder | - |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Founder | - |
Formation de Howard Birndorf
| Wayne State University (Michigan) | Graduate Degree |
| Oakland University (Michigan) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| DMK PHARMACEUTICALS CORPORATION | Health Technology |
| Entreprise privées | 12 |
|---|---|
Ngen, Inc.
 Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Commercial Services |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
FasTraq, Inc.
FasTraq, Inc. Medical SpecialtiesHealth Technology FasTraq, Inc. provides blood diagnosis solutions. The company's product includes FasTraQ ER-CPC workstation. It was founded in 2002 and is headquartered in Henderson, NV. | Health Technology |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
21st Century Media
 21st Century Media Information Technology ServicesTechnology Services Part of Media 100, Inc., 21st Century Media is a private company that provides encoding, hosting, Web casting, and interactive production of streaming media. The company is based in San Francisco, CA. The company was founded by Howard C. Birndorf. 21st Century Media was acquired by Media 100, Inc. on June 12, 2000. | Technology Services |
Gensia Pharmaceuticals, Inc.
 Gensia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gensia Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products for cardiovascular diseases. The company is based in San Diego, CA and has subsidiaries in the United States. The company was founded by Robert L. Engler, Paul K. Laikind. | Health Technology |
Jurilab Oy
 Jurilab Oy Pharmaceuticals: MajorHealth Technology Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland. | Health Technology |
| Ha Cell Technology, Inc. | |
BCM Benefits LLC
BCM Benefits LLC Investment ManagersFinance BCM Benefits LLC provides investment advice. The private company is based in Syracuse, NY. The company was founded by Howard C. Birndorf, Stanley J. Bradshaw. | Finance |
| Birndorf Technology Development | |
| The Coalition for 21st Century Medicine |
